Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Hiroshi Nonogi(Kyoto Medical Center), Yoichi Goto(United Cerebral Palsy), Kenji Kangawa(National Cerebral and Cardiovascular Center), Yuji Miyao(National Cerebral and Cardiovascular Center), Takahiro Matsumoto, Shunichi Miyazaki, Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Yoshio Kobayashi(Chiba University), Satoshi Daikoku(National Cerebral and Cardiovascular Center), Shuichi Takishita(University of the Ryukyus University Hospital), Toshio Nishikimi(Kyoto University), Hiroaki Matsuoka(Social Welfare Department), Isao Morii(Takatsuki General Hospital)
Cited by 180
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485